#88 Lenvatinib plus pembrolizumab versus chemotherapy as first-line therapy for advanced or recurrent endometrial cancer: primary results of the phase 3 ENGOT-en9/LEAP-001 study
Proceedings article published in 2024 by
Christian Marth,
Richard G. Moore,
Mariusz Bidzinski,
Sandro Pignata,
Ali Ayhan,
M. Jesús Rubio,
Mario Beiner,
Marcia Hall,
Christof Vulsteke 
,
Elena Ioana Braicu,
Kenzo Sonoda,
Xiaohua Wu,
Sophia Frentzas,
André Mattar,
Jodi McKenzie
and other authors.
,
Elena Ioana Braicu,
Kenzo Sonoda,
Xiaohua Wu,
Sophia Frentzas,
André Mattar,
Jodi McKenzie
and other authors.
